Valeant No Enron; Stock Market Overreacting says Smith Expert
SMITH BRAIN TRUST -- Valeant Pharmaceuticals’ stock dive, after short-selling resea
Information For:
Centers
- Center for Artificial Intelligence in Business
- Center for Behavioral Finance
- Center for Excellence in Service
- Center for Financial Policy
- Center for Global Business
- Center for Social Value Creation
- Dingman-Lamone Center for Entrepreneurship
- Ed Snider Center for Enterprise and Markets
- Smith Analytics Consortium
- Smith Enterprise Risk Consortium
- Supply Chain Management Center